Email updates

Keep up to date with the latest news and content from BMC Genomics and BioMed Central.

Open Access Highly Accessed Research article

p53 induces distinct epigenetic states at its direct target promoters

Lukas Vrba14, Damian J Junk12, Petr Novak14 and Bernard W Futscher123*

Author Affiliations

1 Arizona Cancer Center, the University of Arizona, Tucson, AZ 85724, USA

2 Cancer Biology Graduate Interdisciplinary Program, the University of Arizona, Tucson, AZ 85724, USA

3 Department of Pharmacology and Toxicology, College of Pharmacy, the University of Arizona, Tucson, AZ 85724, USA

4 Biology Centre ASCR, v.v.i., Institute of Plant Molecular Biology, Ceske Budejovice, 37005, Czech Republic

For all author emails, please log on.

BMC Genomics 2008, 9:486  doi:10.1186/1471-2164-9-486

Published: 15 October 2008

Abstract

Background

The tumor suppressor protein p53 is a transcription factor that is mutated in many cancers. Regulation of gene expression by binding of wild-type p53 to its target sites is accompanied by changes in epigenetic marks like histone acetylation. We studied DNA binding and epigenetic changes induced by wild-type and mutant p53 in non-malignant hTERT-immortalized human mammary epithelial cells overexpressing either wild-type p53 or one of four p53 mutants (R175H, R249S, R273H and R280K) on a wild-type p53 background.

Results

Using chromatin immunoprecipitation coupled to a 13,000 human promoter microarray, we found that wild-type p53 bound 197 promoters on the microarray including known and novel p53 targets. Of these p53 targets only 20% showed a concomitant increase in histone acetylation, which was linked to increased gene expression, while 80% of targets showed no changes in histone acetylation. We did not observe any decreases in histone acetylation in genes directly bound by wild-type p53. DNA binding in samples expressing mutant p53 was reduced over 95% relative to wild-type p53 and very few changes in histone acetylation and no changes in DNA methylation were observed in mutant p53 expressing samples.

Conclusion

We conclude that wild-type p53 induces transcription of target genes by binding to DNA and differential induction of histone acetylation at target promoters. Several new wild-type p53 target genes, including DGKZ, FBXO22 and GDF9, were found. DNA binding of wild-type p53 is highly compromised if mutant p53 is present due to interaction of both p53 forms resulting in no direct effect on epigenetic marks.